RadioGraphics, Vol 17, 453-472, Copyright © 1997 by Radiological Society of North America

ARTICLES

Islet cell tumors of the pancreas: clinical, radiologic, and pathologic correlation in diagnosis and localization [published erratum appears in Radiographics 1997 Jul-Aug;17(4):1010]

PC Buetow, DL Miller, TV Parrino and JL Buck
Department of Radiologic Pathology, Armed Forces Institute of Pathology, Washington, DC 20306-6000, USA.

Islet cell tumors are rare pancreatic or peripancreatic neoplasms that produce and secrete hormones to a variable degree. These tumors are best divided on clinical grounds into those that produce a recognizable, clinically evident endocrine syndrome (ie, functioning) and those that exhibit no clinical evidence of hormone production (ie, clinically silent). Clinically silent tumors produce symptoms due to mass effect because of their large size. They are often partially cystic or necrotic. Functioning islet cell tumors usually manifest earlier in the course of the disease because of the distinctive signs and symptoms of the associated endocrine syndrome. Clinically silent and functioning tumors cannot be histologically distinguished reliably even with the use of immunohistochemical stains. Insulinoma and gastrinoma, the two most common functioning lesions, are typically small homogeneous masses. Other functioning islet cell tumors include glucagonoma, somatostatinoma, vipoma, and adrenocorticotropic hormone- producing tumor. Larger tumors are associated with calcification, cystic degeneration and necrosis, and a more aggressive behavior (local and vascular invasion as well as distant metastases). There are many different techniques for detection and characterization of these lesions that are usually chosen according to the radiologist's experience and preference. Treatment and prognosis of these lesions depend on the hormone produced, their size, and their behavior.

This article has been cited by other articles:

				E. M. Chung, M. D. Travis, and R. M. Conran From the Archives of the AFIP: Pancreatic Tumors in Children: Radiologic-Pathologic Correlation. RadioGraphics, July 1, 2006; 26(4): 1211 - 1238. [Abstract] [Full Text] [PDF]

				K. M. Horton, R. H. Hruban, C. Yeo, and E. K. Fishman Multi-Detector Row CT of Pancreatic Islet Cell Tumors. RadioGraphics, March 1, 2006; 26(2): 453 - 464. [Abstract] [Full Text] [PDF]

				G. A. Kaltsas, G. M. Besser, and A. B. Grossman The Diagnosis and Medical Management of Advanced Neuroendocrine Tumors Endocr. Rev., June 1, 2004; 25(3): 458 - 511. [Abstract] [Full Text] [PDF]

				M K Kalra, M M Maher, P R Mueller, and S Saini State-of-the-art imaging of pancreatic neoplasms Br. J. Radiol., December 1, 2003; 76(912): 857 - 865. [Abstract] [Full Text] [PDF]

				H. B. Marcos, S. K. Libutti, H. R. Alexander, I. A. Lubensky, D. L. Bartlett, M. M. Walther, W. M. Linehan, G. M. Glenn, and P. L. Choyke Neuroendocrine Tumors of the Pancreas in von Hippel-Lindau Disease: Spectrum of Appearances at CT and MR Imaging with Histopathologic Comparison Radiology, December 1, 2002; 225(3): 751 - 758. [Abstract] [Full Text] [PDF]

				T. Ichikawa, M. S. Peterson, M. P. Federle, R. L. Baron, H. Haradome, Y. Kawamori, S. Nawano, and T. Araki Islet Cell Tumor of the Pancreas: Biphasic CT versus MR Imaging in Tumor Detection Radiology, July 1, 2000; 216(1): 163 - 171. [Abstract] [Full Text]